CA2348479A1 - Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof - Google Patents

Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof Download PDF

Info

Publication number
CA2348479A1
CA2348479A1 CA002348479A CA2348479A CA2348479A1 CA 2348479 A1 CA2348479 A1 CA 2348479A1 CA 002348479 A CA002348479 A CA 002348479A CA 2348479 A CA2348479 A CA 2348479A CA 2348479 A1 CA2348479 A1 CA 2348479A1
Authority
CA
Canada
Prior art keywords
hvr
rvr
nucleic acid
polypeptide
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002348479A
Other languages
English (en)
French (fr)
Inventor
Rory A. J. Curtis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals, Inc.
Rory A. J. Curtis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals, Inc., Rory A. J. Curtis filed Critical Millennium Pharmaceuticals, Inc.
Publication of CA2348479A1 publication Critical patent/CA2348479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002348479A 1998-11-13 1999-11-12 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof Abandoned CA2348479A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10832298P 1998-11-13 1998-11-13
US60/108,322 1998-11-13
US11407898P 1998-12-28 1998-12-28
US60/114,078 1998-12-28
US25863399A 1999-02-26 1999-02-26
US09/258,633 1999-02-26
US42113499A 1999-10-19 1999-10-19
US09/421,134 1999-10-19
PCT/US1999/026701 WO2000029577A1 (en) 1998-11-13 1999-11-12 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof

Publications (1)

Publication Number Publication Date
CA2348479A1 true CA2348479A1 (en) 2000-05-25

Family

ID=27493638

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002348479A Abandoned CA2348479A1 (en) 1998-11-13 1999-11-12 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof

Country Status (5)

Country Link
EP (1) EP1131433A1 (de)
JP (1) JP2002531069A (de)
AU (1) AU2148000A (de)
CA (1) CA2348479A1 (de)
WO (1) WO2000029577A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009140A1 (en) 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
DE69910538T2 (de) * 1998-01-22 2004-06-24 The Regents Of The University Of California, Oakland Nukleinsäuresequenzen, welche für capsaicin-rezeptoren kodieren
GB9827016D0 (en) 1998-12-08 1999-02-03 Merck Sharp & Dohme Receptor protein
GB9907097D0 (en) 1999-03-26 1999-05-19 Novartis Ag Organic compounds
US6482611B1 (en) 1999-09-23 2002-11-19 Neurogen Corporation Human capsaicin receptor and uses thereof
ZA200300255B (en) 2000-07-20 2004-09-28 Bristol Myers Squibb Pharma Co Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors.
DE10043674A1 (de) * 2000-09-02 2002-03-21 Gruenenthal Gmbh Antisense Oligonukleotide
WO2002018407A2 (de) * 2000-09-02 2002-03-07 Grünenthal GmbH Antisense oligonukleotide gegen vanilloid rezeptor 1
AU2001297015A1 (en) 2000-10-15 2002-04-29 Ortho-Mcneil Pharmaceutical, Inc. Improved ligand binding assays for vanilloid receptors
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
CA2515418A1 (en) * 2003-02-12 2004-08-26 Bayer Healthcare Ag Hydroxy-tetrahydro-naphthalenylurea derivatives
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
WO2005040119A1 (en) 2003-10-01 2005-05-06 Bayer Healthcare Ag Tetrahydro-naphthalene and urea derivatives
WO2005037095A1 (en) 2003-10-14 2005-04-28 Pelikan Technologies, Inc. Method and apparatus for a variable user interface
WO2005044802A2 (en) 2003-11-08 2005-05-19 Bayer Healthcare Ag Tetrahydro-quinolinylurea derivatives as vrl antagonists
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
BRPI0513286A (pt) 2004-07-15 2008-05-06 Japan Tobacco Inc compostos de benzamida condensada e inibidores de atividade de receptor vanilóide subtipo (vr1), suas composições farmacêuticas, pacote comercial, fármaco e respectivos usos
US7906508B2 (en) 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
EP2265324B1 (de) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integriertes System zur Messung von Analyten
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
JP5644026B2 (ja) * 2009-08-11 2014-12-24 独立行政法人国立循環器病研究センター Ｔｒｐｖ２の部分ペプチド
CA2786853A1 (en) * 2010-02-26 2011-09-01 Ventana Medical Systems, Inc. Cytogenic analysis of metaphase chromosomes
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
WO1999009140A1 (en) * 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
DE69910538T2 (de) * 1998-01-22 2004-06-24 The Regents Of The University Of California, Oakland Nukleinsäuresequenzen, welche für capsaicin-rezeptoren kodieren
WO1999037765A1 (en) * 1998-01-27 1999-07-29 Smithkline Beecham Plc Human vanilloid receptor homologues
EP0943683A1 (de) * 1998-03-10 1999-09-22 Smithkline Beecham Plc Menschliches Vanilloid Rezeptorhomolog Vanilrep1
EP0953638A1 (de) * 1998-03-11 1999-11-03 Synthelabo Dem menschlichen Vanilloid Rezeptor ähnlicher Kationenkanal

Also Published As

Publication number Publication date
WO2000029577A9 (en) 2000-09-28
WO2000029577A1 (en) 2000-05-25
AU2148000A (en) 2000-06-05
JP2002531069A (ja) 2002-09-24
EP1131433A1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
CA2348479A1 (en) Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
US6194151B1 (en) Molecules of the TNF receptor superfamily and uses therefor
US8133689B2 (en) Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
US20030232378A1 (en) Novel toll molecules and uses therefor
US20020099197A1 (en) Novel potassium channel molecules and uses therefor
US6225085B1 (en) LRSG protein and nucleic acid molecules and uses therefor
US20020150988A1 (en) Novel molecules of the FTHMA-070-related protein family and the T85-related protein family and uses thereof
US20020068322A1 (en) 47765, a novel human lysyl oxidase and uses thereof
CA2328902A1 (en) Novel secreted and membrane-associated proteins and uses therefor
WO2002038767A2 (en) G protein-coupled receptor protein and nucleic acid molecules and uses therefor
US20020081658A1 (en) 18610, a novel human transient receptor and uses thereof
CA2351365A1 (en) Potassium channel interactors and uses therefor
US20030124670A1 (en) 43238, a novel G protein-coupled receptor and uses therefor
US20020035056A1 (en) 54420, a novel human calcium channel
US6756212B1 (en) Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof
US20020123098A1 (en) 55063, a novel human NMDA family member and uses thereof
US20020142330A1 (en) Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
US20020123094A1 (en) 57250, a novel human sugar transporter family member and uses thereof
US20030108934A1 (en) 21910, a novel human membrane-associated guanylate kinase and uses thereof
WO2000043514A9 (en) Human acid sensing ion channel and uses thereof
US20020120112A1 (en) Lymphoma associated molecules and uses therefor
CA2348758A1 (en) Lymphoma associated molecules and uses therefor
US20020086982A1 (en) Novel EBI-3-ALT protein and nucleic acid molecules and uses therefor
US20030049727A1 (en) 25658, a novel human calcium channel subunit and uses thereof
US20020177148A1 (en) FBH58295FL, a novel human amino acid transporter and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead